OmniAb is a biotechnology company providing next-generation antibody discovery platforms. Their proprietary OmniAb technology generates diverse, high-quality therapeutic antibody candidates using transgenic animals with human antibody repertoires, combined with high-throughput screening technologies for efficient lead identification across multiple therapeutic modalities and targets.